Novavax to Participate in the Citi 2016 Global Healthcare Conference

GAITHERSBURG, Md., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced the Company will participate in the Citi 2016 Global Healthcare Conference.

Conference details are as follows:

Date: Wednesday, December 7, 2016Location: New York Palace Hotel, New York, New York

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

[email protected]
240-268-2000

Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.

[email protected]
[email protected]
212-845-4271

You May Also Be Interested In

• Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
• USHV Expands to Tennessee Through Partnership with Apex Vascular
• In HelloNation, Custom Signs Experts Joe Infusino-Braun and Cory Wipperfurth Explain Choosing the Right Monument Sign for Your Business